These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3373480)

  • 21. Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model.
    Guchelaar HJ; Vermes I; Koopmans RP; Reutelingsperger CP; Haanen C
    Cancer Chemother Pharmacol; 1998; 42(1):77-83. PubMed ID: 9619762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell kill kinetics of an antineoplastic nucleoside, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytosine.
    Ono T; Fujii A; Yamagami K; Hosoya M; Okumoto T; Sakata S; Matsuda A; Sasaki T
    Biochem Pharmacol; 1996 Oct; 52(8):1279-85. PubMed ID: 8937436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of a new potent antitumor nucleoside, 2'-C-cyano-2'-deoxy-1-beta-D- arabinofuranosylcytosine.
    Matsuda A; Nakajima Y; Azuma A; Sasaki T; Ueda T
    Nucleic Acids Symp Ser; 1990; (22):51-2. PubMed ID: 2101914
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytostatic and cytotoxic effects of (E)-2'-deoxy-2'-(fluoromethylene)-cytidine on a solid tumor and a leukemia cell line.
    Grie P; Koronkiewicz M; Skierski JS
    Acta Biochim Pol; 2000; 47(1):165-71. PubMed ID: 10961690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical pharmacology of the oral fluoropyrimidines.
    Takimoto CH
    Curr Probl Cancer; 2001; 25(3):134-213. PubMed ID: 11408845
    [No Abstract]   [Full Text] [Related]  

  • 26. An improved synthesis of an important S-sialylnucleoside analogue.
    Smalec B; von Itzstein M
    Carbohydr Res; 1995 Jan; 266(2):269-72. PubMed ID: 7697658
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthesis and biological activity of various 3'-azido and 3'-amino analogues of 5-substituted pyrimidine deoxyribonucleosides.
    Lin TS; Gao YS; Mancini WR
    J Med Chem; 1983 Dec; 26(12):1691-6. PubMed ID: 6644738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological activity of 1-(2-deoxy-2-C-fluoromethyl- and 2-C-hydroxymethylarabinofuranosyl)-cytosines.
    Yoshimura Y; Saitoh K; Ashida N; Sakata S; Sasaki T; Matsuda A
    Nucleic Acids Symp Ser; 1993; (29):33-4. PubMed ID: 8247781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of 4'-thio-beta-D-arabinofuranosylcytosine in CEM cells.
    Parker WB; Shaddix SC; Rose LM; Waud WR; Shewach DS; Tiwari KN; Secrist JA
    Biochem Pharmacol; 2000 Dec; 60(12):1925-32. PubMed ID: 11108809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activity of the lipophilic nucleoside derivatives elacytarabine and CP-4126 in a panel of tumor cell lines resistant to nucleoside analogues.
    Sandvold ML; Galmarini C; Myhren F; Peters G
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):386-93. PubMed ID: 20544524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral tumoractivated chemotherapy--an introduction.
    Kaye SB
    Oncology; 1999 Jul; 57 Suppl 1():1. PubMed ID: 10436409
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacology and clinical status of capecitabine.
    Schilsky RL
    Oncology (Williston Park); 2000 Sep; 14(9):1297-306; discussion 1309-11. PubMed ID: 11033828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Palliative chemotherapy for metastatic breast cancer with capecitabine].
    Inaba T; Kashiwaba M; Takeda Y; Komatsu H; Tomisawa Y; Takiyama I; Wakabayashi G
    Gan To Kagaku Ryoho; 2009 May; 36(5):769-72. PubMed ID: 19461175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of 4'-thio-beta-D-arabinofuranosylcytosine (4'-thio-ara-C) and comparison of its anticancer activity with that of ara-C.
    Tiwari KN; Shortnacy-Fowler AT; Cappellacci L; Parker WB; Waud WR; Montgomery JA; Secrist JA
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):329-40. PubMed ID: 10772718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capecitabine in the treatment of advanced gastric cancer.
    Lee JL; Kang YK
    Future Oncol; 2008 Apr; 4(2):179-98. PubMed ID: 18407732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleosides and nucleotides. 100. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosyl-cytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside.
    Matsuda A; Nakajima Y; Azuma A; Tanaka M; Sasaki T
    J Med Chem; 1991 Sep; 34(9):2917-9. PubMed ID: 1895307
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis of 3'- and 5'-nitrooxy pyrimidine nucleoside nitrate esters: "nitric oxide donor" agents for evaluation as anticancer and antiviral agents.
    Naimi E; Zhou A; Khalili P; Wiebe LI; Balzarini J; De Clercq E; Knaus EE
    J Med Chem; 2003 Mar; 46(6):995-1004. PubMed ID: 12620076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic cytotoxicity of recombinant human TNF and various anti-cancer drugs.
    Watanabe N; Niitsu Y; Yamauchi N; Ohtsuka Y; Sone H; Neda H; Maeda M; Urushizaki I
    Immunopharmacol Immunotoxicol; 1988; 10(1):117-27. PubMed ID: 2452179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of thymidylate synthetase in the cytostatic activity of pyrimidine nucleoside analogues.
    Balzarini J
    Bull Mem Acad R Med Belg; 1985; 140(11):432-40. PubMed ID: 3841831
    [No Abstract]   [Full Text] [Related]  

  • 40. Selective radiosensitization and cytotoxicity of human melanoma cells using halogenated deoxycytidines and tetrahydrouridine.
    Lawrence TS; Davis MA
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1243-6. PubMed ID: 2715074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.